Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia. Fehr A, Arvidsson G, Nordlund J, Lonnerholm G, et al. Genes Chromosomes Cancer 2023 May 23. doi: 10.1002/gcc.23151.

Read + Share

Amedeo Smart

Independent Medical Education

Fehr A, Arvidsson G, Nordlund J, Lonnerholm G, et al. Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2023 May 23. doi: 10.1002/gcc.23151.
PMID: 37218648